Pre-earnings options volume in Zevra Therapeutics Inc is normal with calls leading puts 48:1. Implied volatility suggests the market is anticipating a move near 8.4%, or 58c, after results are released. Median move over the past eight quarters is 5.5%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- ZVRA Earnings this Week: How Will it Perform?
- Zevra Therapeutics 9.2M share Spot Secondary priced at $6.50
- Zevra Therapeutics Announces Pricing of Underwritten Offering of Common Stock
- Zevra Therapeutics announces common stock offering, no amount given
- Zevra Therapeutics Announces Proposed Public Offering of Common Stock